المؤلفون: Rina Hui, Scott J. Antonia, Catherine Wadsworth, Suresh Senan, Bradford A. Perez, David Vicente, Davey B. Daniel, A. Villegas, Luis Paz-Ares, David R. Spigel, Mustafa Ozguroglu, Shuji Murakami, Corinne Faivre-Finn, Phillip A. Dennis, Helen Broadhurst, Corey J. Langer

المساهمون: Radiation Oncology, CCA - Cancer Treatment and quality of life

المصدر: Faivre-Finn, C, Spigel, D R, Senan, S, Langer, C, Perez, B A, Özgüroğlu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Paz-Ares, L, Broadhurst, H, Wadsworth, C, Dennis, P A & Antonia, S J 2021, ' Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC) ', Lung Cancer, vol. 151, pp. 30-38 . https://doi.org/10.1016/j.lungcan.2020.11.024Test
Lung Cancer, 151, 30-38. Elsevier Ireland Ltd
Faivre-finn, C, Spigel, D R, Senan, S, Langer, C, Perez, B A, Özgüroğlu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Paz-ares, L, Broadhurst, H, Wadsworth, C, Dennis, P A & Antonia, S J 2020, ' Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC) ', Lung Cancer . https://doi.org/10.1016/j.lungcan.2020.11.024Test

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Cancer Research, medicine.medical_specialty, Randomization, Durvalumab, Lung Neoplasms, Pd-L1 Expression, Docetaxel, Placebo, Vinorelbine, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Median follow-up, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Chemotherapy, Humans, Etoposide, Radiotherapy, business.industry, Antibodies, Monoclonal, Biomarker, Chemoradiotherapy, Concurrent, Carboplatin, Blockade, 030104 developmental biology, Nivolumab, Oncology, chemistry, 030220 oncology & carcinogenesis, Cell Lung-Cancer, Immunotherapy, Cisplatin, business, Non-small-cell lung cancer, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc66d1431e19641df7ad85c29d2fa5d3Test
https://research.vumc.nl/en/publications/a94e824c-5543-4cff-95c7-1dd8269a3f90Test

المؤلفون: Phillip A. Dennis, Michael Newton, Shuji Murakami, A. Villegas, M. Vincent, Mark A. Socinski, Helen Mann, Rina Hui, Scott J. Antonia, Davey B. Daniel, Keunchil Park, David Vicente, Mustafa Ozguroglu, Jhanelle E. Gray

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Male, Cancer Research, medicine.medical_specialty, Durvalumab, Lung Neoplasms, Survival, Immune-checkpoint inhibitors, Placebo, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, In patient, Patient Reported Outcome Measures, Lung cancer, Adverse effect, Aged, Patient-reported outcomes, business.industry, Hazard ratio, Antibodies, Monoclonal, Chemoradiotherapy, medicine.disease, Stage III Non-Small Cell Lung Cancer, Concurrent chemoradiotherapy, Exploratory analysis, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Safety, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76af519faebbedb9b884a946e8cbe4ffTest
https://hdl.handle.net/20.500.12831/6950Test

المؤلفون: David Planchard, Shuji Murakami, S.J. Antonia, Corey J. Langer, Anne-Marie Boothman, Helen Broadhurst, David Vicente, Byoung Chul Cho, Suresh Senan, C. Wadsworth, David Raben, Davey B. Daniel, Phillip A. Dennis, Alexander I. Spira, David R. Spigel, Bradford A. Perez, Corinne Faivre-Finn, Rina Hui, Luis Paz-Ares, Mustafa Ozguroglu, A. Villegas

المساهمون: İÜC, Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radiation Oncology

المصدر: Ann Oncol
Paz-Ares, L, Spira, A, Raben, D, Planchard, D, Cho, B C, Özgüroğlu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Spigel, D, Senan, S, Langer, C J, Perez, B A, Boothman, A M, Broadhurst, H, Wadsworth, C, Dennis, P A, Antonia, S J & Faivre-Finn, C 2020, ' Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial ', Annals of Oncology, vol. 31, no. 6, pp. 798-806 . https://doi.org/10.1016/j.annonc.2020.03.287Test
Paz-Ares, L, Spira, A, Raben, D, Planchard, D, Cho, B C, Özgüroğlu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Spigel, D, Senan, S, Langer, C J, Boothman, A-M, Broadhurst, H, Wadsworth, C, Dennis, P A, Antonia, S J & Faivre-Finn, C 2020, ' Outcomes with durvalumab by tumour PD-L1 expression in unresectable, Stage III non-small-cell lung cancer in the PACIFIC trial ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 31, no. 6, pp. 798-806 . https://doi.org/10.1016/j.annonc.2020.03.287Test
Annals of oncology : official journal of the European Society for Medical Oncology, 31(6), 798-806. Oxford University Press

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Durvalumab, PACIFIC, Lung Neoplasms, durvalumab, stage III, PD-L1 expression, Placebo, Gastroenterology, Article, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Stage (cooking), Lung cancer, Proportional hazards model, business.industry, Hazard ratio, Antibodies, Monoclonal, Hematology, medicine.disease, Stage III Non-Small Cell Lung Cancer, 030104 developmental biology, Oncology, non-small-cell lung cancer, 030220 oncology & carcinogenesis, immunotherapy, business, Chemoradiotherapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2821de1574e6e128fc443bb253fe17d8Test
https://europepmc.org/articles/PMC8412232Test/

المؤلفون: Maria Jose Flor, David Vicente, Christoph Helwig, Luis Paz-Ares, Massimo Di Nicola, Tae Min Kim, Enriqueta Felip, James L. Gulley, Byoung Chul Cho, Laureen S. Ojalvo, Chia-Chi Lin, Rosa Maria Alvarez, Isabelle Dussault, Dae Ho Lee, Ki Hyeong Lee

المصدر: J Thorac Oncol

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, PD-L1, TGF-β, medicine.medical_specialty, M7824, Lung Neoplasms, medicine.medical_treatment, NSCLC, Gastroenterology, Article, B7-H1 Antigen, Bintrafusp alfa, 03 medical and health sciences, 0302 clinical medicine, Transforming Growth Factor beta, Internal medicine, Carcinoma, Non-Small-Cell Lung, Clinical endpoint, medicine, Humans, Adverse effect, business.industry, Antibodies, Monoclonal, Immunotherapy, Discontinuation, 030104 developmental biology, Oncology, Tolerability, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Cohort, business, Adjuvant

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2d6615b1900eacd384b206400e01c8Test
http://www.jto.org/article/S1556086420301957/pdfTest

المؤلفون: Scott J. Antonia, A. Villegas, Alberto Chiappori, Catherine Wadsworth, David Planchard, Shuji Murakami, Maria Taboada, David R. Spigel, Luis Paz-Ares, Mustafa Ozguroglu, Davey B. Daniel, David Vicente, Ki Hyeong Lee, Takayasu Kurata, Johan Vansteenkiste, Byoung Chul Cho, Jhanelle E. Gray, Phillip A. Dennis, Corinne Faivre-Finn, Rina Hui

المساهمون: İÜC, Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Durvalumab, PACIFIC, Lung Neoplasms, Population, Stage III NSCLC, Three-year update, Placebo, NSCLC, Gastroenterology, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Overall survival, education, Neoplasm Staging, education.field_of_study, business.industry, Hazard ratio, Antibodies, Monoclonal, Chemoradiotherapy, Confidence interval, Regimen, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, business

وصف الملف: application/pdf; Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1199512dca88a291a15bb416207a181fTest
https://hdl.handle.net/10668/14900Test